Cargando…
Inflammatory Status and Glycemic Control Level of Patients with Type 2 Diabetes and Periodontitis: A Randomized Clinical Trial
Background: Based on the holistic approach to prevention diabetic disease, the role of periodontal inflammation in type 2 diabetes mellitus (T2DM) is under intensive scrutiny. Data from clinical trials have shown benefit from a periodontal therapy in providing patients with type 2 diabetes improveme...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998112/ https://www.ncbi.nlm.nih.gov/pubmed/33804123 http://dx.doi.org/10.3390/ijerph18063018 |
_version_ | 1783670476634062848 |
---|---|
author | Rapone, Biagio Ferrara, Elisabetta Corsalini, Massimo Qorri, Erda Converti, Ilaria Lorusso, Felice Delvecchio, Maurizio Gnoni, Antonio Scacco, Salvatore Scarano, Antonio |
author_facet | Rapone, Biagio Ferrara, Elisabetta Corsalini, Massimo Qorri, Erda Converti, Ilaria Lorusso, Felice Delvecchio, Maurizio Gnoni, Antonio Scacco, Salvatore Scarano, Antonio |
author_sort | Rapone, Biagio |
collection | PubMed |
description | Background: Based on the holistic approach to prevention diabetic disease, the role of periodontal inflammation in type 2 diabetes mellitus (T2DM) is under intensive scrutiny. Data from clinical trials have shown benefit from a periodontal therapy in providing patients with type 2 diabetes improvement despite relatively disappointing long-terms response rates. The aim of this study was to investigate the short-term glycemic control level and systemic inflammatory status after periodontal therapy. Methods: This was a randomized trial with a 6-months follow-up. Participants aged 56.4 ± 7.9 years with diagnosed type 2 diabetes and periodontitis were enrolled. Among the 187 type 2 diabetic patients, 93 were randomly assigned to receive non-surgical periodontal treatment immediately and 94 to receive the delayed treatment. Within and between groups comparison was done during the study period, and the differences between groups were assessed. Results: The difference between HbA1c values at baseline (Mdn = 7.7) and 6 months after non-surgical periodontal treatment (Mdn = 7.2) was statistically significant, U = 3174.5, p = 0.012, r = 0.187. However, although technically a positive correlation, the relationship between the glycated hemoglobin value and periodontal variables was weak. The differences between both the groups over 6 months were not statistically considerable, failing to reach statistical significance. At 6 months the difference between groups about the C-reactive protein (CRP) levels was statistically significant, U=1839.5, p = 0, r = 0.472, with a lower concentration for the intervention group. Furthermore, the intervention group showed a statistically significant difference between baseline and 6 months evaluation (U = 2606.5, p = 0, r = 0.308). Conclusions: The periodontal intervention potentially may allow individuals with type 2 diabetes to improve glycemic control and CRP concentrations, and diabetes alters the periodontal status. |
format | Online Article Text |
id | pubmed-7998112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79981122021-03-28 Inflammatory Status and Glycemic Control Level of Patients with Type 2 Diabetes and Periodontitis: A Randomized Clinical Trial Rapone, Biagio Ferrara, Elisabetta Corsalini, Massimo Qorri, Erda Converti, Ilaria Lorusso, Felice Delvecchio, Maurizio Gnoni, Antonio Scacco, Salvatore Scarano, Antonio Int J Environ Res Public Health Article Background: Based on the holistic approach to prevention diabetic disease, the role of periodontal inflammation in type 2 diabetes mellitus (T2DM) is under intensive scrutiny. Data from clinical trials have shown benefit from a periodontal therapy in providing patients with type 2 diabetes improvement despite relatively disappointing long-terms response rates. The aim of this study was to investigate the short-term glycemic control level and systemic inflammatory status after periodontal therapy. Methods: This was a randomized trial with a 6-months follow-up. Participants aged 56.4 ± 7.9 years with diagnosed type 2 diabetes and periodontitis were enrolled. Among the 187 type 2 diabetic patients, 93 were randomly assigned to receive non-surgical periodontal treatment immediately and 94 to receive the delayed treatment. Within and between groups comparison was done during the study period, and the differences between groups were assessed. Results: The difference between HbA1c values at baseline (Mdn = 7.7) and 6 months after non-surgical periodontal treatment (Mdn = 7.2) was statistically significant, U = 3174.5, p = 0.012, r = 0.187. However, although technically a positive correlation, the relationship between the glycated hemoglobin value and periodontal variables was weak. The differences between both the groups over 6 months were not statistically considerable, failing to reach statistical significance. At 6 months the difference between groups about the C-reactive protein (CRP) levels was statistically significant, U=1839.5, p = 0, r = 0.472, with a lower concentration for the intervention group. Furthermore, the intervention group showed a statistically significant difference between baseline and 6 months evaluation (U = 2606.5, p = 0, r = 0.308). Conclusions: The periodontal intervention potentially may allow individuals with type 2 diabetes to improve glycemic control and CRP concentrations, and diabetes alters the periodontal status. MDPI 2021-03-15 /pmc/articles/PMC7998112/ /pubmed/33804123 http://dx.doi.org/10.3390/ijerph18063018 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rapone, Biagio Ferrara, Elisabetta Corsalini, Massimo Qorri, Erda Converti, Ilaria Lorusso, Felice Delvecchio, Maurizio Gnoni, Antonio Scacco, Salvatore Scarano, Antonio Inflammatory Status and Glycemic Control Level of Patients with Type 2 Diabetes and Periodontitis: A Randomized Clinical Trial |
title | Inflammatory Status and Glycemic Control Level of Patients with Type 2 Diabetes and Periodontitis: A Randomized Clinical Trial |
title_full | Inflammatory Status and Glycemic Control Level of Patients with Type 2 Diabetes and Periodontitis: A Randomized Clinical Trial |
title_fullStr | Inflammatory Status and Glycemic Control Level of Patients with Type 2 Diabetes and Periodontitis: A Randomized Clinical Trial |
title_full_unstemmed | Inflammatory Status and Glycemic Control Level of Patients with Type 2 Diabetes and Periodontitis: A Randomized Clinical Trial |
title_short | Inflammatory Status and Glycemic Control Level of Patients with Type 2 Diabetes and Periodontitis: A Randomized Clinical Trial |
title_sort | inflammatory status and glycemic control level of patients with type 2 diabetes and periodontitis: a randomized clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998112/ https://www.ncbi.nlm.nih.gov/pubmed/33804123 http://dx.doi.org/10.3390/ijerph18063018 |
work_keys_str_mv | AT raponebiagio inflammatorystatusandglycemiccontrollevelofpatientswithtype2diabetesandperiodontitisarandomizedclinicaltrial AT ferraraelisabetta inflammatorystatusandglycemiccontrollevelofpatientswithtype2diabetesandperiodontitisarandomizedclinicaltrial AT corsalinimassimo inflammatorystatusandglycemiccontrollevelofpatientswithtype2diabetesandperiodontitisarandomizedclinicaltrial AT qorrierda inflammatorystatusandglycemiccontrollevelofpatientswithtype2diabetesandperiodontitisarandomizedclinicaltrial AT convertiilaria inflammatorystatusandglycemiccontrollevelofpatientswithtype2diabetesandperiodontitisarandomizedclinicaltrial AT lorussofelice inflammatorystatusandglycemiccontrollevelofpatientswithtype2diabetesandperiodontitisarandomizedclinicaltrial AT delvecchiomaurizio inflammatorystatusandglycemiccontrollevelofpatientswithtype2diabetesandperiodontitisarandomizedclinicaltrial AT gnoniantonio inflammatorystatusandglycemiccontrollevelofpatientswithtype2diabetesandperiodontitisarandomizedclinicaltrial AT scaccosalvatore inflammatorystatusandglycemiccontrollevelofpatientswithtype2diabetesandperiodontitisarandomizedclinicaltrial AT scaranoantonio inflammatorystatusandglycemiccontrollevelofpatientswithtype2diabetesandperiodontitisarandomizedclinicaltrial |